Ulcerative Colitis Treatment: Why Bristol Myers' Success Sent Arena Stock Flying – Investor's Business Daily

Business News

  1. Ulcerative Colitis Treatment: Why Bristol Myers’ Success Sent Arena Stock Flying  Investor’s Business Daily
  2. Bristol-Myers Squibb’s stock rises on Zeposia trial findings, launch in the U.S.  MarketWatch
  3. Bristol Myers Reveals Positive Results For Ulcerative Colitis Pivotal Trial  Yahoo Finance
  4. Here’s Why Arena Pharmaceuticals Jumped Higher Today  Motley Fool
  5. Bristol Myers’ Treatment Succeeds in Late-Stage Bowel Disease Study  The New York Times
  6. View Full Coverage on Google News

Source: Business News

/by